About 2 results found for searched term "EIDD-1931" (0.439 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9605 | Molnupiravir (EIDD-2801) | Anti-infection |
| MK-4482; pro-EIDD-1931; CAS#2492423-29-5 | ||
| Molnupiravir (EIDD-2801) is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. | ||
| M29908 | EIDD-1931 | Anti-infection |
| β-D-N4-hydroxycytidine; NHC | ||
| EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
